Boosting axitinib exposure with a CYP3A4 inhibitor, making axitinib treatment personal

  • Floor J. E. Lubberman, Nielka P. van Erp, Rob ter Heine, Carla M. L. van Herpen
  • Acta Oncologica, April 2017, Taylor & Francis
  • DOI: 10.1080/0284186x.2017.1311024

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/0284186x.2017.1311024